Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Change in Receivables (2016 - 2026)

Nutex Health (NUTX) has disclosed Change in Receivables for 16 consecutive years, with $20.1 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Receivables rose 2967.07% year-over-year to $20.1 million; the TTM value through Mar 2026 reached $21.8 million, down 87.49%, while the annual FY2025 figure was $2.4 million, 98.63% down from the prior year.
  • Change in Receivables hit $20.1 million in Q1 2026 for Nutex Health, up from -$152.6 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $169.7 million in Q4 2024 and bottomed at -$152.6 million in Q4 2025.
  • Average Change in Receivables over 5 years is $8.4 million, with a median of $656000.0 recorded in 2025.
  • Year-over-year, Change in Receivables plummeted 30079.22% in 2022 and then surged 61900.0% in 2024.
  • Nutex Health's Change in Receivables stood at -$54.8 million in 2022, then soared by 104.86% to $2.7 million in 2023, then soared by 6268.85% to $169.7 million in 2024, then crashed by 189.91% to -$152.6 million in 2025, then soared by 113.19% to $20.1 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods came in at $20.1 million, -$152.6 million, and $152.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.